{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:53:10Z","timestamp":1790239990094,"version":"4.1.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1001\/jamapediatrics.2018.5044","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T09:39:58Z","timestamp":1548322798000},"page":"234","source":"Crossref","is-referenced-by-count":53,"title":["Pharmacological Treatments for Neonatal Abstinence Syndrome"],"prefix":"10.1001","volume":"173","author":[{"given":"Timothy","family":"Disher","sequence":"first","affiliation":[{"name":"Dalhousie University School of Nursing, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Gullickson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balpreet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Cameron","sequence":"additional","affiliation":[{"name":"Cornerstone Research Group Inc, Burlington, Ontario, Canada"},{"name":"Faculty of Graduate Studies, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Boulos","sequence":"additional","affiliation":[{"name":"Maritime SPOR Support Unit, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Beaubien","sequence":"additional","affiliation":[{"name":"Faculty of Management, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Campbell-Yeo","sequence":"additional","affiliation":[{"name":"Dalhousie University School of Nursing, Halifax, Nova Scotia, Canada"},{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada"},{"name":"Department of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"poi180090r1","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal.","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"poi180090r2","doi-asserted-by":"publisher","first-page":"e20173520","DOI":"10.1542\/peds.2017-3520","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004-2014.","volume":"141","author":"Winkelman","year":"2018","journal-title":"Pediatrics"},{"issue":"185","key":"poi180090r3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.drugalcdep.2017.12.019","article-title":"Trends in incidence of neonatal abstinence syndrome in Canada and associated healthcare resource utilization.","volume":"185","author":"Filteau","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"poi180090r4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/jp.2014.114","article-title":"Variation in treatment of neonatal abstinence syndrome in US children\u2019s hospitals, 2004-2011.","volume":"34","author":"Patrick","year":"2014","journal-title":"J Perinatol"},{"key":"poi180090r6","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"8","key":"poi180090r9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial.","volume":"172","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"24","key":"poi180090r10","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","article-title":"Buprenorphine for the treatment of the neonatal abstinence syndrome.","volume":"376","author":"Kraft","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"poi180090r11","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1542\/peds.2014-2377","article-title":"Morphine versus clonidine for neonatal abstinence syndrome.","volume":"135","author":"Bada","year":"2015","journal-title":"Pediatrics"},{"key":"poi180090r12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12887-015-0377-9","article-title":"Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial.","volume":"15","author":"Nayeri","year":"2015","journal-title":"BMC Pediatr"},{"issue":"4","key":"poi180090r13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/jp.2014.194","article-title":"Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.","volume":"35","author":"Brown","year":"2015","journal-title":"J Perinatol"},{"issue":"12","key":"poi180090r14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jp.2013.95","article-title":"Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome: a prospective randomized clinical trial.","volume":"33","author":"Surran","year":"2013","journal-title":"J Perinatol"},{"issue":"3","key":"poi180090r15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/add.2011.106.issue-3","article-title":"Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.","volume":"106","author":"Kraft","year":"2011","journal-title":"Addiction"},{"issue":"5","key":"poi180090r16","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1542\/peds.2008-0978","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.","volume":"123","author":"Agthe","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"poi180090r17","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1542\/peds.2008-0571","article-title":"Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial.","volume":"122","author":"Kraft","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"poi180090r18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.07.001","article-title":"Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops.","volume":"77","author":"Langenfeld","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"poi180090r19","doi-asserted-by":"publisher","first-page":"F300","DOI":"10.1136\/adc.2003.033555","article-title":"A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome.","volume":"89","author":"Jackson","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"poi180090r20","first-page":"353","article-title":"Neonatal abstinence syndrome, pharmacotherapy and developmental outcome.","volume":"8","author":"Kaltenbach","year":"1986","journal-title":"Neurobehav Toxicol Teratol"},{"key":"poi180090r21","first-page":"282","article-title":"An evaluation of neonatal abstinence treatment modalities.","volume":"49","author":"Finnegan","year":"1984","journal-title":"NIDA Res Monogr"},{"key":"poi180090r22","first-page":"329","article-title":"The use of phenobarbital in treating abstinence in newborns exposed in utero to psychoactive agents.","volume":"49","author":"Finnegan","year":"1984","journal-title":"NIDA Res Monogr"},{"issue":"12","key":"poi180090r23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archpedi.1983.02140380026008","article-title":"Neonatal methadone withdrawal: effect of two treatment regimens.","volume":"137","author":"Carin","year":"1983","journal-title":"Am J Dis Child"},{"issue":"4","key":"poi180090r24","first-page":"378","article-title":"Opiate v CNS depressant therapy in neonatal drug abstinence syndrome.","volume":"137","author":"Kandall","year":"1983","journal-title":"Am J Dis Child"},{"issue":"2","key":"poi180090r25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0002-9378(16)33250-1","article-title":"Observation and treatment of neonatal narcotic withdrawal.","volume":"127","author":"Madden","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"poi180090r26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0022-3476(69)80281-7","article-title":"The course of the heroin withdrawal syndrome in newborn infants treated with phenobarbital or chlorpromazine.","volume":"75","author":"Kahn","year":"1969","journal-title":"J Pediatr"},{"issue":"3","key":"poi180090r27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/rssa.12341","article-title":"Sensitivity of treatment recommendations to bias in network meta-analysis.","volume":"181","author":"Phillippo","year":"2018","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"5","key":"poi180090r28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"issue":"2","key":"poi180090r31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"poi180090r32","doi-asserted-by":"publisher","first-page":"F300","DOI":"10.1136\/adc.2003.033555","article-title":"A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome.","volume":"89","author":"Jackson","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"poi180090r33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000242196","article-title":"Laudanum versus phenobarbital in neonatal abstinence syndrome therapy.","volume":"48","author":"Fabris","year":"1985","journal-title":"Biol Neonate"},{"key":"poi180090r34","article-title":"Effect of randomized paregoric (PA) or phenobabital (PB) treatment on neonatal drug withdrawal.","author":"Kandall","year":"1980","journal-title":"Pediatr Res"},{"issue":"5","key":"poi180090r35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-3835","article-title":"Improving care for neonatal abstinence syndrome.","volume":"137","author":"Patrick","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"poi180090r36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jpeds.2015.09.038","article-title":"Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome.","volume":"167","author":"Hall","year":"2015","journal-title":"J Pediatr"},{"issue":"4","key":"poi180090r37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis.","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"13","key":"poi180090r38","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment.","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"poi180090r39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/hpeds.2017-0077","article-title":"Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016.","volume":"8","author":"Milliren","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"7","key":"poi180090r40","doi-asserted-by":"publisher","first-page":"e0159267","DOI":"10.1371\/journal.pone.0159267","article-title":"Empirical evidence of study design biases in randomized trials: systematic review of meta-epidemiological studies.","volume":"11","author":"Page","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"poi180090r43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1891\/0730-0832.35.5.314","article-title":"Pharmacotherapy for neonatal abstinence syndrome: Choosing the right opioid or no opioid at all.","volume":"35","author":"McPherson","year":"2016","journal-title":"Neonatal Netw"},{"issue":"6","key":"poi180090r44","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1542\/peds.110.6.1182","article-title":"The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.","volume":"110","author":"Lester","year":"2002","journal-title":"Pediatrics"},{"key":"poi180090r29","volume-title":"Baynesian Data Analysis","author":"Gelman","year":"2016","edition":"3rd ed"},{"key":"poi180090r30","volume-title":"Handling Continuous Outcomes in Quantitative Synthesis. Methods Guide for Comparative Effectiveness Reviews","author":"Fu","year":"2013"},{"key":"poi180090r41","doi-asserted-by":"crossref","DOI":"10.1002\/9781118951651","volume-title":"Network Meta-analysis for Decision-Making","author":"Dias","year":"2018"},{"key":"poi180090r42","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-analysis","author":"Borenstein","year":"2009"},{"key":"poi180090r5","unstructured":"Veritas Health Innovation. Covidence systematic review software. http:\/\/www.covidence.org. Accessed September 20, 2018."},{"key":"poi180090r7","unstructured":"R Core Team. R: A language and environment for statistical computing. https:\/\/cran.r-project.org\/. Accessed September 20, 2018."},{"key":"poi180090r8","unstructured":"DiasS, WeltonNJ, SuttonAJ, AdesA. NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK310366\/pdf\/Bookshelf_NBK310366.pdf. Accessed September 20, 2018."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamapediatrics\/article-pdf\/173\/3\/234\/17301955\/jamapediatrics_disher_2019_oi_180090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T11:04:11Z","timestamp":1551697451000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpedi.jamanetwork.com\/article.aspx?doi=10.1001\/jamapediatrics.2018.5044"}},"subtitle":["A Systematic Review and Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2018.5044","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734903564.793555945","asserted-by":"object"}]},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}